drugset / Trial / NCT02015637

Comparison of Delafloxacin Versus Ceftriaxone for the Treatment of Uncomplicated Gonorrhea

NCT02015637

Phase 3 Terminated 460 enrolled Melinta Therapeutics, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effects of a single oral dose of delafloxacin versus a single intramuscular injection of ceftriaxone in subjects with uncomplicated cervical, urethral, rectal, or pharyngeal gonorrhea.

Timeline

Start
2014-01-23
Primary completion
2014-11
Completion
2014-12-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ceftriaxone Other / unclassified 250 mg Intramuscular
Subject Delafloxacin Small molecule 900 mg Oral

Indications